Digital therapeutics available only in a limited number of European countries

Creating a structured approach to the authorization, launch and use of digital therapeutics has the potential to improve healthcare across Europe, empower patients and bring significant financial benefits to healthcare systems, according to a new report out today by the European Federation of Pharmaceutical Industries and Associations (EFPIA). EFPIA is today publishing a number of policy recommendations which aims to improve access to these technologies across all Member States.

Digital therapeutics which could help transform patient care available only in a limited number of European countries (efpia.eu)